ACLSACLS
US • —
$189.45
P/E
59.00
PEG
—
FCF Yield
—
Rev Growth YoY
-11.8% YoY
Gross Margin
43.6%
Health Score
5/10
D/E Ratio
0.04
Confidence
MEDIUM
Business Snapshot
Axcelis Technologies designs, manufactures, and services ion implantation equipment used in the fabrication of semiconductor chips. The company operates in the capital equipment segment of the semiconductor industry, a cyclical but essential niche where precision doping of silicon wafers is required. Axcelis is a focused player in this specialized market, competing against larger diversified equipment suppliers like Applied Materials. A defining characteristic of the company is its single-segment concentration in ion implantation, making its financial performance highly sensitive to semiconductor capital spending cycles.
Financial Health
The company maintains a gross margin of 43.6%, though net margin (TTM) stands at a lower 11.9%, reflecting the operating costs of a manufacturing business. The balance sheet is exceptionally conservative, with a Debt/Equity ratio of just 0.04x and a robust Current Ratio of 4.77x, indicating ample short-term liquidity and very low leverage...
Risk Assessment
- VALUATION — P/E of 59.0x is 2.7x the sector average of 22x, leaving little room for error if growth disappoints.
- EARNINGS QUALITY — Earnings beat estimates in 3 of 4 quarters, but the underlying net income declined 41.1% YoY, a divergence that raises questions about the reliability of forward guidance.
- REVENUE DECELERATION — Revenue declined 11.8% year-over-year, a sharp reversal from any prior growth trend, signaling a demand contraction.
- TECHNICALS — RSI, MACD, and moving average data unavailable for this period; momentum cannot be independently confirmed....
The company maintains a gross margin of 43.6%, though net margin (TTM) stands at a lower 11.9%, reflecting the operating costs of a manufacturing business. The balance sheet is exceptionally conservative, with a Debt/Equity ratio of just 0.04x and a robust Current Ratio of 4.77x, indicating ample short-term liquidity and very low leverage. Free cash flow data is unavailable, preventing a full assessment of cash generation quality. Overall, the financial position is strong from a solvency perspective, providing resilience through downturns and capacity for reinvestment, but the lack of cash flow data and a narrow single-digit net margin warrant caution.
- VALUATION — P/E of 59.0x is 2.7x the sector average of 22x, leaving little room for error if growth disappoints. - EARNINGS QUALITY — Earnings beat estimates in 3 of 4 quarters, but the underlying net income declined 41.1% YoY, a divergence that raises questions about the reliability of forward guidance. - REVENUE DECELERATION — Revenue declined 11.8% year-over-year, a sharp reversal from any prior growth trend, signaling a demand contraction. - TECHNICALS — RSI, MACD, and moving average data unavailable for this period; momentum cannot be independently confirmed.
Unlock the full AI report
Full 8-section analysis includes:
Metric deep-dives